Tumor necrosis factor inhibitor ameliorates murine intestinal graft- versus-host disease

Gastroenterology

Volumn 116, Issue 3, 1999, Pages 593-601

  Brown, G R ^a   Lindberg, G ^a   Meddings, J ^a   Silva, M ^a   Beutler, B ^a   Thiele, D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; TUMOR NECROSIS FACTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; ENTEROPATHY; FEMALE; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; INTESTINE TRANSPLANTATION; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0033011210     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70181-2     Document Type: Article

References (27)

1. DL Thiele ML Eigenbrodt SE Bryde HH Eigenbrodt PE. Lipsky Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes J Clin Invest 83 1989 1947 1956
2. ML Eigenbrodt EH Eigenbrodt DL. Thiele Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease Am J Pathol 137 1990 1065 1076
3. JL. Ferrara Cytokine inhibitors and graft-versus-host disease Ann NY Acad Sci 770 1995 227 236
4. R Korngold J. Sprent Surface markers of T cells causing lethal graft-versus-host disease to class I vs class II H-2 differences J Immunol 135 1985 3004 3010
5. S Koide LD McVay WL Frankel CA Behling ED Zhou T Shimada W Zhang JL. Rombeau Increased expression of tissue cytokines in graft-versus-host disease after small bowel transplantation in the rat Transplantation 64 1997 518 524
6. DA Vallera PA Taylor JL Vannice A Panoskaltsis-Mortari BR. Blazer Interleukin 1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice Transplantation 60 1995 1371 1374
7. PF Piguet GE Grau B Allet P. Vassalli Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease J Exp Med 166 1987 1280 1289
8. DE Speiser MF Bachmann TW Frick K McKall-Faienza E Griffiths K Pfeffer TW Mak PS. Ohashi TNF receptor p55 controls early acute graft-versus-host disease J Immunol 158 1997 5185 5190
9. J Kolls K Peppel M Silva B. Beutler Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer Proc Natl Acad Sci USA 91 1994 215 219
10. K Peppel D Crawford B. Beutler A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity J Exp Med 174 1991 1483 1489
11. + T lymphocytes J Immunol 154 1995 3686 3695
12. GR Brown DL Thiele M Silva B. Beutler Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium Gastroenterology 112 1997 1586 1594
13. Z Zsengeller S Wert W Hull X Hu X Yei B Trapnell J. Whitsett Persistence of replication deficient adenovirus mediated gene transfer in lungs of immune-deficient (nu/nu) mice Hum Gene Ther 6 1995 457 467
14. JB Meddings I. Gibbons Discrimination of site-specific alterations in gastrointestinal permeability in the rat Gastroenterology 114 1998 83 92
15. WA Stack SD Mann AJ Roy P Heath M Sopwith J Freeman G Holmes R Long A Forbes MA Kamm CJ. Hawkey Randomised controlled trial for CDP571 antibody to tumor necrosis factor α in Crohn's disease Lancet 349 1997 521 524
16. HM van Dullemen SJ van Deventer DW Hommes HA Bijl J Jansen GN Tytgat J. Woody Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
17. P-F. Piguet GVHD elucidated by products of class I or class II lock of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHD induced mortality, medullary aplasia, and enteropathy J Immunol 135 1985 1637 1643
18. D Guy Grand P. Vassalli Gut injury in mouse graft-versus-host reaction: study of its occurrence and mechanism J Clin Invest 77 1986 1584 1595
19. AM Mowat A Borand DMV. Parrott Hypersensitivity reactions in the small intestine VII. Induction of the intestinal phase of murine graft-versus-host reaction by Lyt 2-T cells activated by I-A alloantigens Transplantation 41 1986 192 198
20. P Herve M Flesch P Tiberghien J Wijdenes E Racadot P Bordigoni E Plouvier JL Stephan H Bourdeau E Holler B Lioure C Roche E Vilmer F Demeocq M Kuentz JY. Cahn Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease Blood 79 1992 3362 3368
21. E Holler HJ Kolb J Mittermuller M Kaul G Ledderose T Duell B Seeber M Schleuning R Hintermeier-Knabe B Ertl J Kempeni W. Wilmanns Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F) Blood 86 1995 890 899
22. SR Targan SB Hanauer SJ van Deventer L Mayer DH Present T Braakman KL DeWoody TF Schaible PJ. Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group N Engl J Med 337 1997 1029 1035
23. CA Dinarello JG Cannon SM Wolff HA Bernheim B Beutler A Cerami IS Figari MA Palladino JV. O'Connor Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 J Exp Med 163 1986 1433 1450
24. JS Pober MA Gimborne LA Lapierre DL Mendrick W Fiers R Rothlein TA. Springer Overlapping pattern of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon J Immunol 137 1986 1893 1896
25. JFR Ker CJ Bishop J. Searle Apoptosis in recent advances in histopathology P Anthony N Roderick M MacSween 1984 Churchill Livingstone London 1 15
26. E Duval AH. Wyllie Death and the cell Immunol Today 7 1986 115 119
27. RJ Jon Hilden JB Meddings LR. Sutherland Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease Gastroenterology 110 1996 1395 1403